NCT06732388 2026-04-13
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
16 trialsNCT03753659 2026-03-23
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT07416448 2026-02-18
NAP-C/R
Ukrainian Society of Regional Anesthesia and Pain Therapy
Phase NA Recruiting
NCT07206121 2026-02-11
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Innoblative Designs, Inc.
Phase NA Recruiting
NCT02437071 2025-12-05
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT07247565 2025-11-25
Comparative Study Between Conventional Radiofrequency Ablation vs Chemical Neurolysis of Ganglion Impar for Treatment of Chronic Non Cancer Related Coccydynia
Ain Shams University
Phase NA Active not recruiting
NCT01153035 2025-11-10
ABLATE
University of Arkansas
Phase NA Active not recruiting
NCT02558504 2025-10-02
HARMONI
Hospices Civils de Lyon
Phase 4 Completed
NCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
NCT04389216 2025-09-15
RFA
Hospital Universitari de Bellvitge
Phase NA Completed
NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT07095803 2025-07-31
Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure
Fudan University
Phase 2 Not yet recruiting
NCT06903208 2025-07-18
RFA for Superficial Lipomas
Columbia University
Phase NA Recruiting
NCT05142904 2025-07-17
RABITO
Rijnstate Hospital
Phase 3 Terminated
NCT04520932 2025-05-25
RFANET
Institut Paoli-Calmettes
Phase NA Recruiting
NCT04522570 2025-04-30
Thermal Ablation of Cervical Metastases From Thyroid Carcinoma
Instituto do Cancer do Estado de São Paulo
Phase NA Active not recruiting